- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04595760
Factors Influencing Fertility or Pregnancy Health
Background:
The North Carolina Early Pregnancy Study (EPS) was held from 1982 to 1986. Women who were trying to get pregnant took part in the study. They collected urine samples. They kept diaries. They filled out surveys. They answered questions about their partners. They were asked about their drug use. Data about air pollution and other exposures were also collected. A follow-up study was held from 2010 to 2011. Researchers want to use the data and samples to study factors that affect reproductive success.
Objective:
To examine behavioral and environmental exposures and reproductive health, such as menstrual cycles, conception, pregnancy loss, and pregnancy outcomes.
Eligibility:
The 221 healthy women age 21-42 who were planning to get pregnant and took part in the 1982-86 North Carolina EPS at the time they stopped using all birth control. A 2010-11 follow-up included 173 of these women.
Design:
This study uses existing data. No new data will be collected in this study.
Stored urine samples may be used. Data from surveys and other sources will be used. All of the women who gave data and samples will be included.
Electronic data is held in secure databases. The data is kept on computers that are password protected. Hard-copy data are stored in locked file cabinets.
The study will take place at more than one site. Data will be shared with groups outside the NIH.
Study Overview
Status
Detailed Description
Existing self-reported data and assay results from the 1982-1986 North Carolina Early Pregnancy Study (EPS) and a subsequent 2010-2011 cohort follow-up study will be used to examine predictors of fertility and pregnancy outcomes. Some of these data will be harmonized with data from other studies by our collaborator (Harville PI, Tulane University) to examine factors, such as marijuana use in women and their partners, influencing reproductive success, including (but not limited to) conception, pregnancy loss, and birth outcomes. Women enrolled in the original EPS study after discontinuing birth control and were followed for the occurrence of a pregnancy. Participants completed daily diaries and collected first morning urine specimens which allowed the identification of hormonal endpoints. Thus, each woman s time to pregnancy was prospectively measured. In the EPS Follow-up study, women completed a questionnaire that included their recall of their time to pregnancy during the study. This allowed analysis of two major questions, one regarding the recall of time- to-pregnancy, and the other regarding the natural length of gestation. Several exposure metrics based on address geolocation data were calculated, including the distance from residence to nearest major road, air pollution and related exposures, light at night, and other exposures. Existing urine specimens can be assayed for numerous environmental contaminants including metals, pesticides, and drug metabolites (both over-the-counter medications like acetaminophen and drugs of abuse like marijuana or opioids). Urine specimens can also be used to examine nutritional markers such as phytoestrogen exposure and caffeine metabolites. Additional hormone measures may also be possible as metabolomics and technology improve. Thus, the stored EPS specimens can be leveraged to answer multiple, relevant fertility research questions. Women in the original tudy answered questions regarding their tobacco smoking and marijuana smoking. In addition, partners of the women were asked the same series of questions regarding tobacco and marijuana use.
We intend to use all of this existing data, assay results, and to perform additional urine assays, to examine factors influencing reproductive success, including (but not limited to) conception, pregnancy loss, and birth outcomes. To address some of these questions, de-identified data from the Early Pregnancy Study will be harmonized with data from other studies in the Preconception Period Analysis of Risks and Exposures Influencing Health and Development (PrePARED) consortium. Further, de-identified data and specimens will be shared with Dr. Ashley Boggs and colleagues to address the objectives below. Data and specimens will be shared with other qualified investigators in the future to address relevant research questions.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institute of Environmental Health Sciences (NIEHS)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
- INCLUSION CRITERIA:
- healthy white women aged 21-42 who were planning to become
pregnant
-women enrolled in the 1982-1986 North Carolina Early Pregnancy
Study (EPS) at the time they discontinued all methods of birth control
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
EPS Study Participants
Women who participated in the 1982-1986 North Carolina Early Pregnancy Study (EPS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time-to-pregnancy
Time Frame: Prospectively measured
|
Reproductive function includes a spectrum of relevant endpoints and outcomes.
We will examine behavioral and environmental exposures and reproductive health including menstrual cycles, conception, pregnancy loss, and pregnancy outcomes
|
Prospectively measured
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy loss, hormone levels, birth outcomes, pregnancy complications
Time Frame: Prospectively measured
|
Reproductive function includes a spectrum of relevant endpoints and outcomes.
We will examine behavioral and environmental exposures and reproductive health including menstrual cycles, conception, pregnancy loss, and pregnancy outcomes.
|
Prospectively measured
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anne Marie Z Jukic, Ph.D., National Institute of Environmental Health Sciences (NIEHS)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10000058
- 000058-E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menstrual Cycles
-
SPD Development Company LimitedCompleted
-
SPD Development Company LimitedCompleted
-
SPD Development Company LimitedCompleted
-
Izmir University of EconomicsCompleted
-
Oregon Health and Science UniversitySociety of Family PlanningCompletedOvulation (Follicular Rupture Yes/no) | Menstrual Cycles (Total Length, Bleeding Days) | Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)United States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownProgesterone,Hormone Replacement Thawed Embryo Transfer Cycles
-
Reproductive Medicine Associates of New JerseyCompletedEffect of PGD on Implantation Rates in IVF CyclesUnited States
-
Taipei Medical University WanFang HospitalCompletedIrregular Menstrual Cycle | Regular Menstrual CycleTaiwan
-
Hülya ULAŞLI KABANNot yet recruitingDisabled People | Menstrual Hygiene Management | Menstrual Cup
-
Batman UniversityCompletedWomens Health | Menstrual Management | Generational Differences | Menstrual HealthTurkey (Türkiye)